Sickle-cell Anemia Therapeutics Market in the US 2015-2019, to grow at a CAGR of 17.10%, Key Vendors - Bristol-Myers Squibb, Future Prominent Vendors and Ohter
"Sickle-cell Anemia Therapeutics Market in the US 2015-2019" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- About Sickle-cell Anemia Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=879294 TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019. Covered in this Report